In this issue of Blood, Raghu et al provide exciting new data implicating transglutaminase factor XIII (fXIII) in rheumatoid arthritis in mice. The study presents compelling evidence demonstrating that fXIII contributes to arthritis pathogenesis through distinct mechanisms linked to inflammation and destructive bone loss.